TrialAlimentary pharmacology & therapeutics2018
Long-term efficacy and safety of ustekinumab for Crohn's disease through the second year of therapy.
W J Sandborn et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
85 papers cite itlatest 60 shown
this paperpooled ittrialcites it